Has Anil Jonnalagadda, MD received payments from drug or device companies?

Yes. Drug and device makers reported $532 in general payments to Anil Jonnalagadda, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anil Jonnalagadda, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anil Jonnalagadda, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anil Jonnalagadda, MD

Cardiovascular Disease · Fort Worth, TXNPI 1386083343

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $443 of the $532 with a category attached, or 83.3%. 8 manufacturers reported payments, led by Cook Medical LLC at 24.2% of the total. Reporting peaked in 2019 at $229 and has fallen 61.1% since, to $89 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in TX, where the typical reported total is $3,258.

$532in general payments, 2019–2025

Across 11 payments — averaging $48.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cook Medical LLC$129
Amgen$103
Actelion Pharmaceuticals US, Inc.$89
Boston Scientific$79
Abbott$42
Impulse Dynamics (USA) Inc.$40
plus $51 from 2 others

What the payments were for

Food & beverage$44383%
Education$8917%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cook Medical LLC	1	$129
Amgen	1	$103
Actelion Pharmaceuticals US, Inc.	1	$89
Boston Scientific	2	$79
Abbott	2	$42
Impulse Dynamics (USA) Inc.	2	$40
Medtronic	1	$33
E.r. Squibb & Sons, L.L.C.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Cook Medical Aortic Intervention$129
Repatha$103

How this compares

$532 in reported general payments places this provider in the 20th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Medicare billing

Part B allowed, 2024

$46,065

Medicare patients

712

Services billed

1,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	37	$48,131
JardianceEmpagliflozin	34	$45,450
EntrestoSacubitril/Valsartan	15	$18,346
Repatha SureclickEvolocumab	17	$9,382
Metoprolol Succinate	72	$795
Atorvastatin Calcium	93	$745
Spironolactone	94	$708
Losartan Potassium	46	$558
Carvedilol	75	$496
Rosuvastatin Calcium	29	$488
Amlodipine Besylate	110	$462
Metoprolol Tartrate	66	$430
Furosemide	59	$333
ClopidogrelClopidogrel Bisulfate	40	$315
Lisinopril	49	$261

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Fort Worth

Ramin Farzaneh-FarDallas$17.1M
John OsborneGrapevine$1.3M
Darren McGuireDallas$1.2M
Peter McCulloughDallas$664K
Ann NavarDallas$616K
Biykem BozkurtHouston$606K
Milton PackerDallas$530K
Amarinder BindraDallas$512K
Robert SalazarKingwood$478K
Reynolds DelgadoHouston$471K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →